Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Monday, August 17, 2020

Medical therapy may prevent strokes in asymptomatic carotid stenosis

 I personally think that the proper solution to this is:

1. Determine if Circle of Willis is complete.

2. If yes, then close up the offending artery, no chance of throwing clots to brain, no stroke risk from carotid endarterectomy.

But I'm not medically trained so don't listen to me, but have your doctor GUARANTEE NO STROKE FROM ANY INTERVENTION CHOSEN. 

'May' is way too wishy-washy.

Medical therapy may prevent strokes in asymptomatic carotid stenosis

Absolute risk reduction for fatal and nonfatal strokes in patients who underwent early carotid endarterectomy was less than half the risk difference from trials initiated 20 years ago, researchers found.

The study published in JAMA Neurology also determined that this absolute reduction was no longer statistically significant when accounting for the competing risk for nonstroke deaths.

 

“Given the upfront perioperative risks associated with carotid endarterectomy, initial medical therapy may be an equally acceptable treatment strategy for the management of patients with asymptomatic carotid stenosis,” Salomeh Keyhani, MD, MPH, professor of medicine at University of California, San Francisco, School of Medicine, and colleagues wrote.

In this comparative effectiveness study, researchers assessed data from 5,221 veterans aged at least 65 years who underwent carotid imaging from 2005 to 2009. Patients were excluded if they had carotid stenosis less than 50%, hemodynamically insignificant stenosis and a history of transient ischemic attack or stroke 6 months before imaging was performed.

Two cohorts were formed: patients assigned initial medical therapy (n = 2,509; mean age, 74 years; 99% men) and those assigned carotid endarterectomy (n = 2,712; mean age, 74 years; 99% men). Both treatment options were given within 1 year after index carotid imaging. Follow-up was conducted for 5 years. Analyses used in the Asymptomatic Carotid Surgery Trial were emulated in this trial to estimate the comparative effectiveness of carotid endarterectomy and initial medical therapy to prevent nonfatal and fatal strokes.

The rate of stroke or death within 30 days of carotid endarterectomy was 2.5% (95% CI, 2-3.1). At 5 years, the risk for fatal and nonfatal stroke was lower in the carotid endarterectomy group vs. the initial medical therapy group (5.6% vs. 7.8%; risk difference, 2.3%; 95% CI, 4 to 0.3).

When the competing risk for death was incorporated, the risk difference between patients assigned carotid endarterectomy and those assigned initial medical therapy was lower and not statistically significant (risk difference, 0.8%; 95% CI, 2.1 to 0.5).

In patients who met randomized controlled trial inclusion criteria, the risk for fatal and nonfatal strokes at 5 years was 5.5% (95% CI, 4.5-6.5) for the carotid endarterectomy group and 7.6% (95% CI, 5.7-9.5) for the initial medical therapy group (risk difference, 2.1%; 95% CI, 4.4 to 0.2). A risk difference of 0.9% resulted when accounting for competing risks (95% CI, 2.9 to 0.7).

“The decreased stroke risk in patients with carotid artery stenosis, the persistent upfront perioperative risks and the small difference in stroke risk between the two treatment strategies suggest that patients treated with carotid endarterectomy would now require a longer time to accrue enough stroke reduction benefit to justify the upfront risks of the surgical procedure,” Keyhani and colleagues wrote.

 

No comments:

Post a Comment